Webinar – Speed Without Compromise: From Complex Antibodies to Targeted Delivery

The future of biologics will be defined not only by scientific innovation, but by the ability to develop increasingly complex molecules with speed, quality, and manufacturability.

As therapeutic modalities evolve from monoclonal antibodies to bispecifics, antibody fragments, and targeted delivery systems, development challenges continue to grow. Success increasingly depends on robust CMC strategies that reduce risk while accelerating timelines.

Join experts from ProBio as they share real-world case studies and proven approaches for advancing complex biologics from candidate selection to tox-ready material. Learn how innovative solutions in cell line development, process development, and formulation can help bring next-generation therapeutics to the clinic faster and with greater confidence.